Dana Boyle sold $728K of Liquidia (LQDA)

Executed Nov 7 2025, disclosed Nov 12 2025, 5 days later.

Value, as filed

$728K

29,004 sh across 2 lots

Executed

Nov 7 2025

the trade date, as filed

Disclosed

Nov 12 2025

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DB Dana Boyle Chief Accounting Officer profile →

Dana Boyle (Chief Accounting Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $728K of LQDA (29,004 sh across 2 lots, as filed), executed Nov 7 2025.

The name

LQDA Liquidia Corporation LQDA · Healthcare · 93 filings in 24 months ticker →

Healthcare · Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Dana Boyle in LQDA

LQDASALE Liquidia Corporation $140K
1,600 sh × $87.53
Exec Jul 27
Filed Jul 29 · 4:30 PM ET LQDASALE Liquidia Corporation $598K
8,361 sh × $71.52
Exec Jul 13
Filed Jul 14 · 7:59 PM ET LQDASALE Liquidia Corporation $196K
5,101 sh × $38.37
Exec Apr 13
Filed Apr 14 · 5:30 PM ET LQDASALE Liquidia Corporation $413K
11,047 sh × $37.43
Exec Jan 12
Filed Jan 13 · 5:30 PM ET